Adolescent Psychiatrist Beatrix Hamburg Dies

A champion of peer counseling and a barrier-breaker for black women, she passed away after a battle with Alzheimer’s disease.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

YOUTUBE, YALE UNIVERSITYPsychiatrist Beatrix Hamburg, who studied school violence and peer counseling, died last Sunday (April 15) from Alzheimer’s disease. She was 94.

Hamburg was the first self-identifying black woman admitted to Vassar College and the first black woman to graduate from the Yale School of Medicine, where she became interested in behavioral studies and psychiatry. Her daughter, Margaret Hamburg, was the commissioner of the US Food and Drug Administration from 2009 to 2015.

“She became one of the nation’s leading experts on the problems of adolescence and different stages of adolescence . . . during an era in which most people simply didn’t really think about them in any particular way or fashion,” Jack Barchas, chairman of Weill Cornell Medical College’s psychiatry department, said in a 2015 video that announced a humanitarian prize awarded to Hamburg and her husband, psychiatrist David Hamburg.

Throughout her career, Hamburg held ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies